Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.
<h4>Background</h4>Praziquantel (PZQ) is the only widely available drug to treat schistosomiasis. Given the potential for drug resistance, it is prudent to search for novel therapeutics. Identification of anti-schistosomal chemicals has traditionally relied on phenotypic (whole organism)...
Guardado en:
Autores principales: | Maha-Hamadien Abdulla, Debbie S Ruelas, Brian Wolff, June Snedecor, Kee-Chong Lim, Fengyun Xu, Adam R Renslo, Janice Williams, James H McKerrow, Conor R Caffrey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e07426d1155142edb442dafbc6846ea9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery
por: Steven Chen, et al.
Publicado: (2020) -
A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni.
por: Conor R Caffrey, et al.
Publicado: (2009) -
Mapping survey of schistosomiasis and soil-transmitted helminthiases towards mass drug administration in The Gambia.
por: Yaya Camara, et al.
Publicado: (2021) -
Evaluation of mass drug administration for schistosomiasis and soil-transmitted helminths in school-aged children in Bankass, Mali
por: Moussa Sangare, et al.
Publicado: (2021) -
Research-driven schistosomiasis mass drug administration campaign in four Tanzanian villages along Lake Victoria
por: J.M. Lu, et al.
Publicado: (2016)